Archives genentech

by in
Entry Author Date Location
Houston Dares to Challenge the Bicoastal Model of Biotech Growth 06/23/15 Texas
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus 06/11/15 Seattle
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
At Exelixis, Morrissey Dreams Of Getting the Band Back Together 06/01/15 San Francisco
Denali Rises With $217M and Genentech Alumni to Fight Brain Diseases 05/14/15 San Francisco
Moderna’s Third mRNA Startup, Elpidera, Sets Sights on Rare Diseases 05/12/15 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Seragon CEO Rich Heyman Is Going on Hiatus 02/20/15 San Diego
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
FDA’s Hamburg Stepping Down With Biopharma Turnaround as Her Legacy 02/05/15 National
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Page 1 of 17 next page »